Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will make a presentation regarding the company on January 14, 2014, at 11:00 A.M. PT during the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco. A question and answer session with investors will follow the presentation.
Help employers find you! Check out all the jobs and post your resume.
